Stock Events

Stock Events

Palatin Technologies 

$12.70
148
-$0.38-2.91% Friday 20:00
-$1.10-8.65%Friday 23:30After hours

Statistics

Day High
12.7
Day Low
12.7
52W High
31
52W Low
5.61
Volume
349
Avg. Volume
-
Mkt Cap
22.6M
P/E Ratio
90.91
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q3 2024
Q4 2024
Q1 2025
Q3 2025
Q4 2025
Q1 2026
Next
-2.86
-0.49
1.89
4.26
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-17.31MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PTN. It's not an investment recommendation.
Apple
21
AAPL
Palantir Technologies
19
PLTR
Tesla
17
TSLA
Amazon
16
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap233.78B
Amgen develops therapeutics in areas similar to Palatin, including reproductive health and cardiovascular diseases, making them direct competitors in the biopharmaceutical market.
Pfizer
PFE
Mkt Cap159.36B
Pfizer competes with Palatin in the development of novel drugs, including treatments in sexual health, where Palatin has a significant focus.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly offers products in men's health and other areas that overlap with Palatin's focus, particularly in treatments for conditions like erectile dysfunction.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie, with its broad range of pharmaceutical products, competes in the same therapeutic areas as Palatin, including women's health and hormonal therapies.
Merck
MRK
Mkt Cap366B
Merck operates in various healthcare segments that compete with Palatin, including the development of drugs for sexual health and cardiovascular diseases.
Novartis
NVS
Mkt Cap292.35B
Novartis competes with Palatin in multiple areas, including cardiovascular and metabolic conditions, through its extensive research and development in these fields.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb's diverse range of pharmaceutical products in areas like cardiovascular diseases places it in competition with Palatin Technologies.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline has a presence in the sexual health market, making it a competitor to Palatin, especially in the development of treatments for related conditions.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca's work in cardiovascular and metabolic diseases competes with Palatin's research and development efforts in similar therapeutic areas.

Holdings

About

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
Show more...
CEO
Carl Spana
Employees
29
Country
United States
ISIN
US6960776010
WKN
000A3DTUW

Listings

STU
DE
PTN.STU
BATS
US
PTNT
LSE
GB
0KF3.LSE
XNAS
US
PTN

0 Comments

Share your thoughts

FAQ

What is Palatin Technologies stock price today?▼
The current price of PTN is $12.70 USD — it has decreased by -2.91% in the past 24 hours. Watch Palatin Technologies stock price performance more closely on the chart.
What is Palatin Technologies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Palatin Technologies stocks are traded under the ticker PTN.
What is Palatin Technologies market cap?▼
Today Palatin Technologies has the market capitalization of 22.6M
When is the next Palatin Technologies earnings date?▼
Palatin Technologies is going to release the next earnings report on November 16, 2026.
What were Palatin Technologies earnings last quarter?▼
PTN earnings for the last quarter are -0.37 USD per share, whereas the estimation was -1.24 USD resulting in a +70.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Palatin Technologies revenue for the last year?▼
Palatin Technologies revenue for the last year amounts to 0 USD.
What is Palatin Technologies net income for the last year?▼
PTN net income for the last year is -17.31M USD.
How many employees does Palatin Technologies have?▼
As of September 05, 2026, the company has 29 employees.
In which sector is Palatin Technologies located?▼
Palatin Technologies operates in the Health & Wellness sector.
When did Palatin Technologies complete a stock split?▼
The last stock split for Palatin Technologies was on August 31, 2022 with a ratio of 1:25.
Where is Palatin Technologies headquartered?▼
Palatin Technologies is headquartered in CRANBURY, United States.